Clinical Edge Journal Scan

Ketogenic diet may improve sleep complaints in patients with migraine


 

Key clinical point: Ketogenic diet (KD) significantly improved sleep complaints in patients with migraine, irrespective of migraine improvements and anthropometric modifications.

Major finding: Migraine intensity, headache frequency, and the severity of headache-related disability improved significantly after 3 months of KD therapy (all P < .001) along with a significant decrease in the rate of insomnia (before vs after treatment: 60% vs 40%; P < .001) and number of patients experiencing poor sleep (reduced to half at follow-up; P < .001). The modifications in sleep features showed no correlation with migraine improvements and anthropometric changes.

Study details: This study included 70 patients with migraine who received KD as a preventive therapy for migraine.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Merlino G et al. Sleep of migraine patients is ameliorated by ketogenic diet, independently of pain control. Sleep Med. 2023;107:196-201 (May 9). doi: 10.1016/j.sleep.2023.05.006

Recommended Reading

Update on Migraine Prevention 2023
Migraine ICYMI
Commentary: CGRP medications, COVID-19, and menopause in patients with migraine, June 2023
Migraine ICYMI
New diagnostic criteria for menstrual migraine
Migraine ICYMI
Concomitant oral preventive treatment may dampen response in chronic migraine treated with onabotulinumtoxinA
Migraine ICYMI
Efficacy of galcanezumab after 1 week of treatment for migraine predicts responders at 3 months
Migraine ICYMI
Perimenstrual migraine attacks are exclusively migraine attacks without aura, recommends study
Migraine ICYMI
Real-world data show benefits of anti-CGRP mAb in migraine patients age ≥ 65 years
Migraine ICYMI
Fremanezumab switch may benefit migraine patients who are not responding to anti-CGRP mAb
Migraine ICYMI
Opioid use more frequent in patients with chronic migraine
Migraine ICYMI
Migraine history raises susceptibility to Alzheimer’s disease
Migraine ICYMI